Ori, Jason, and Vincent discuss the use of antibodies to neutralize amyloid-β seeds before their deposition becomes detectable in transgenic mice, and the finding that the preclinical phase of Alzheimer‘s disease may be a late manifestation of earlier pathogenic seed formation.
Become a patron of TWiN!
Links for this episode
- Reducing Alzheimer-like pathology in mice (Nat Neurosci) 2:56, 25:43
- Letters read on TWiN 13 57:25
- Timestamps by Jolene. Thanks!
Music is by Ronald Jenkees
Send your neuroscience questions and comments to email@example.com